|
|
Karl-Heinz |
|
Baringhaus |
|
Site Director R&D Frankfurt |
Sanofi |
https://proventainternational.com/wp-content/uploads/2024/06/Karl-Heinz-Baringhaus.jpg |
Karl-Heinz Baringhaus obtained his Ph.D. in synthetic organic chemistry at the University of Münster. After a postdoctoral fellowship at Stanford University he joined Hoechst AG in 1990 where he was working six years in Medicinal Chemistry. He then moved into Molecular Modeling and in 2000 became Head of Computational Chemistry at Aventis Pharma. From 2005 to 2010 he was Director of Drug Design at Sanofi-Aventis Pharma Deutschland GmbH. In 2010 he was promoted to Head of Structure, Design & Informatics consisting of Computational Biology & Bioinformatics, Computer-aided Drug Design, Scientific Computing & Data Management as well as Structural Biology. Since 2012, Karl-Heinz has been R&D Site Director in Frankfurt. |
|
|
Nessa |
|
Carson |
|
Associate Principal Scientist, Digital Champion |
AstraZeneca |
https://proventainternational.com/wp-content/uploads/2024/06/Nessa-Carson.jpg |
Nessa Carson received Master’s degrees in synthesis and catalysis from Oxford University and the University of Illinois at Urbana-Champaign.
She started her career as a synthetic chemist for AMRI, then moved within the company to run the high-throughput automation facility for Eli Lilly in Windlesham, working across discovery and process chemistry, then in high-throughput reaction optimization at Pfizer and then Syngenta. Nessa moved to AstraZeneca Early Chemical Development in 2022 as Digital Champion, focusing on digital transformation. She was awarded the Salters’ Institute Centenary Award for early-career chemists with the potential to make an outstanding long-term contribution to industrial chemistry. |
|
|
Josef |
|
Eiblmaier |
|
Head of Research, Discovery and Pre-Clinical, PharmaLex |
a Cencora company |
https://proventainternational.com/wp-content/uploads/2024/06/Josef-Eiblmaier.jpg |
Josef Eiblmaier has more than two decades of successful commercial project and solutions experience in cheminformatics, life sciences, pharmaceuticals, biotechnology, and in the intellectual property sector. He currently heads the Discovery, Research, and Preclinical service line at PharmaLex, a Cencora company (formerly OSTHUS).
After completing his PhD in Technical Chemistry at the Technical University of Munich, Josef started his career at InfoChem, where he held various positions in marketing, business development, product development and management before joining OSTHUS in 2021. |
|
|
Peter |
|
Ertl |
|
Formerly Director of Cheminformatics, Biomedical Research |
Novartis |
https://proventainternational.com/wp-content/uploads/2024/06/Peter-Ertl.jpg |
Peter Ertl studied organic chemistry and received his PhD at the University of Bratislava. Then he joined Ciba-Geigy in Basel as a molecular modeler. After a merger with Sandoz to form Novartis, he became Head of the Cheminformatics group in Pharma Research, responsible for development of new methods for calculation of molecular properties and cheminformatics web tools for medicinal chemists.
Peter is author of more than 130 publications covering all areas of cheminformatics and computational chemistry. His major research interests include analysis and visualization of chemical space, bioisosteric design and interactive web tools supporting the work of medicinal chemists.
In the cheminformatics community Peter is known as the author of several cheminformatics algorithms that have become industry standards, including a fast fragment based method to calculate molecular polar surface area and methods to calculate synthetic accessibility or natural-products likeness of molecules. |
|
|
Jeremy |
|
Frey |
|
Head Computational Systems Chemistry |
University of Southampton |
https://proventainternational.com/wp-content/uploads/2024/06/Jeremy-Frey.jpg |
Jeremy Frey is a physical and digital chemist, interested in promoting interdisciplinary research across the physical and life sciences, from laser spectroscopy and imaging, computational modeling, and digital chemical duals.
He was the PI of the AI for Scientific Discovery Network and he is a co-I on the Physical Science Data Infrastructure project. For his most recent project, Jeremy is working with the Rosalind Franklin Institute to develop a laser driven high resolution soft x-ray microscope for biological imaging in the water window. |
|
|
Thrasyvoulos |
|
Karydis |
|
Co-founder, Chief Technology Officer |
DeepCure |
https://proventainternational.com/wp-content/uploads/2024/06/Thrasyvoulos-Karydis-2.jpg |
Thrasyvoulos (Thras) Karydis is the CTO at DeepCure, an AI-driven biotechnology company focusing on inflammation and autoimmune diseases. Thras is leading the development of DeepCure’s groundbreaking AI platform, and he is a thought leader on computational tools and software for small molecule design and automated chemistry.
He is an alumni of the Molecular Machines of MIT Media Lab and the MIT Center for Bits and Atoms. |
|
|
Jessica |
|
Lanini |
|
Biomedical Research |
Novartis Institutes |
https://proventainternational.com/wp-content/uploads/2024/06/Jessica-Lanini.jpg |
Jessica Lanini joined the CADD group at Novartis Institutes for Biomedical Research (NIBR) as a Data Scientist in 2020. She supports MedChem project teams with machine learning and deep learning tools to accelerate DMTA cycle and compound prioritization. She has an MSc in Bioengineering from Campus Bio-medico of Rome since 2014, with a master thesis at ETH, Zurich, on robot control systems and human experiments.
She earned her PhD in Intelligent Systems and Robotics at EPFL, Lausanne, in 2019, focusing on data analysis, modeling and control of bipedal physical interaction while walking. |
|
|
Timur |
|
Madzhidov |
|
Senior Product Manager in Chemistry Innovation |
Elsevier |
https://proventainternational.com/wp-content/uploads/2024/06/Timur-Madzhidov.jpg |
Timur Madzhidov is a Senior Product Manager for Reaxys at Elsevier. With expertise in chemoinformatics, he is a recognized researcher and educator who has co-authored over 70 scientific publications in the fields of reaction informatics, AI application in chemistry, algorithmic chemoinformatics, and chemistry-aware machine learning.
In his role at Elsevier, he leverages his experience in chemoinformatics and the application of artificial intelligence in chemistry to support the success of Reaxys users by delivering improved search and predictive capabilities, implementing new features, and enhancing the readiness of Reaxys data for AI and ML applications. Additionally, he collaborates with academic organizations to support Reaxys R&D efforts, which aim to advance reaction and molecular informatics by providing access to extensive chemistry data.
Prior to joining Elsevier, Timur held academic positions in cheminformatics and molecular modeling. |
|
|
Adrian |
|
Stevens |
|
Chief Product Officer |
Chemaxon |
https://proventainternational.com/wp-content/uploads/2023/09/Adrian-Stevens-1.jpg |
Adrian Stevens joined Chemaxon as Chief Product Officer in 2022. Adrian has spent approximately 15 years working in Life Sciences software companies, in product management roles for most of his time.
As a computational chemist at BioFocus PLC, over the course of nearly 10 years, he supported a wide range of areas in therapeutic research, from oncology, metabolic diseases, autoimmune and pain-based medicines. During this time, he specialized in designing small molecule drugs that targeted protein kinases and GPCR proteins, leading to a number of scientific publications and patents.
Adrian has a PhD in Computational Chemistry from the University of Portsmouth. |
|
|
Becky |
|
Upton |
|
President |
Pistoia Alliance |
https://proventainternational.com/wp-content/uploads/2024/06/Becky-Upton.jpg |
Becky Upton was appointed as the Pistoia Alliance’s first female President in June 2022. She is a long-time supporter of pre-competitive collaboration in life sciences and healthcare R&D and the critical role it plays in advancing science and is passionate about diversity in STEM. Becky is responsible for leading the Pistoia Alliance’s strategy and defining its future within areas of increasing importance to the industry, such as data standards, emerging technologies, diversity and inclusion, sustainability, and precision medicine.
Becky first engaged with the Pistoia Alliance on its Lab of the Future project whilst at VWR (now part Avantor) where she worked for over a decade in sales, business development, and scientific services. From here, she joined the scientific instrumentation and analytical services company, Pion, as Managing Director, before moving to the Alliance as a project manager. She later became Chief Portfolio Officer and within this role established the Alliance’s first and thriving Diversity and Inclusion in STEM Leadership program. Becky re-joined the Alliance as President after a return to the commercial world as a Director at Impellam Group where she led the company’s STEM services strategy.
Becky has a PhD in Biochemistry from Imperial College and an MBA from Cranfield University. |
Hotel Pullman Basel Europe Clarastrasse 43 4058 Basel, Switzerland
Payment Securely powered by stripe
